Agilent introduces bath-free dissolution apparatus

Published: 3-Nov-2011 Featured companies: Agilent Technologies
Analysis

For testing the release rate of pharmaceutical products

Agilent Technologies has introduced the 709-DS dissolution apparatus, which is used to test the release profile of many dosage forms.

The apparatus has a bath-free design that provides an unobstructed view of the dissolution vessel. It also offers increased efficiency through rapid media heating and elimination of water bath cleaning. Vessel media is heated through Agilent’s direct vessel heating system. The instrument is based on the proven 708-DS platform for consistent performance and offers support for a range of workflows.

Automated sample collection and online ultraviolet dissolution integration are available as options to increase laboratory productivity and efficiency.

Featured companies

Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables,...
See more

You may also like

Analysis

Agilent's chromatographic technologies make it easier

Read more
Don’t miss the opportunity to drive efficiency and reduce operational cost with USP 621 revisions

Trending Articles

  1. Huber Huber Kältemaschinenbau SE is the technology leader for high precision thermoregulation solutions in research and industry. Huber products ensure precise temperature control throughout the whole world in laboratories, pilot plants and production processes. Our product range offers temperature control solutions for applications from -125°C to +425°C.
  2. Biotech Fluidics AB At Biotech Fluidics, our aim is to help you make your analytical work more effective and reliable.
  3. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  4. Labtex Labtex is a specialist laboratory and process chemistry equipment solutions provider. A dynamic team of professionals with expertise in research and process development across a wide range of industries and disciplines.
  5. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032

Relevant companies

See more

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Analysis

Agilent's chromatographic technologies make it easier

Don’t miss the opportunity to drive efficiency and reduce operational cost with USP 621 revisions
Analysis

The expert's guide to pharmaceutical impurity analysis

Download new eBook from Agilent now
Analysis

Butterworth continues to invest in new equipment

Butterworth Laboratories provides independent, contract analytical services to the global pharmaceutical industry
Analysis

Breaking 10 bad dissolution habits

Ten tips to help you identify and break bad habits in the lab that can save you time and cut costs
Regulatory

Agilent collaborates with APC on real-time process monitoring

The two companies have committed to combining their technologies to provide unique workflows to customers that support automated process analysis via liquid chromatography
Regulatory

Agilent announces the Cary 3500 UV-Vis Spectrophotometer Compatibility with OpenLab

Ensuring compliance and superior data integrity for pharma and biopharma labs
Regulatory

New breakthroughs increase the efficiency of Critical Quality Attribute (CQA) testing and allow for a Multi- Attribute Method (MAM)

Download new breakthroughs increase the efficiency of Critical Quality Attribute (CQA) testing and allow for a Multi- Attribute Method (MAM) compendium
Subscribe now